DaVita (DVA)
(Delayed Data from NYSE)
$139.01 USD
+0.87 (0.63%)
Updated Apr 30, 2024 04:00 PM ET
After-Market: $139.04 +0.03 (0.02%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
DVA 139.01 +0.87(0.63%)
Will DVA be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for DVA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DVA
DaVita HealthCare (DVA) Increases Despite Market Slip: Here's What You Need to Know
Amedisys (AMED) Q1 Earnings and Revenues Surpass Estimates
DVA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Philips' (PHG) Zenition 30 to Boost Image-Guided Surgeries
Is Trending Stock DaVita Inc. (DVA) a Buy Now?
Neogen (NEOG) Inks Genomics Deal to Aid in Food Tracing
Other News for DVA
Doctors perform first combined heart pump and pig kidney transplant surgery
DaVita Reaches Analyst Target Price
DaVita's Global Operations Powered by 100% Renewable Energy
Goldman picks top capex and R&D stocks
DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call